CUSIP N51517105SHSQ3 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ3 2025
21 funds hold this security · Q3 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Shay Capital LLC | 2.55M | $3.98M | +2.55M | New |
| 2 | Redmile Group, LLC | 2.07M | $3.24M | 0 | Held |
| 3 | Bml Capital Management, LLC | 1.97M | $3.07M | 0 | Held |
| 4 | Sanofi | 1.92M | $2.99M |
| Held |
| 5 | Merck & Co., Inc. | 1.15M | $1.79M | 0 | Held |
| 6 | Gts Securities LLC | 200.0K | $312.0K | +200.0K | New |
| 7 | Rangeley Capital, LLC | 165.0K | $257.4K | +137.9K | Added |
| 8 | Pnc Financial Services Group, Inc. | 65.0K | $101.4K | 0 | Held |
| 9 | Citadel Advisors LLC | 53.3K | $83.2K | +1.5K | Added |
| 10 | Royal Bank Of Canada | 44.3K | $69.0K | +44.3K | New |
See every fund holding Lava Therapeutics NV, with full quarter-over-quarter share changes.
Unlock all holders